Frost edit · Free shipping over $70 · Cool essentials
eccogene glp-1

eccogene glp-1 Non‐clinical and first‐in‐human characterization of ECC5004/AZD5004, a novel once‐daily, oral small‐molecule GLP‐1 receptor agonist - Haggag - 2025 - Diabetes, Obesity and Metabolism 9 Companies Developing Next-Generation GLP-1

SKU: 53686482356
4.4
USD20.62 USD48.62

Pay in 4 interest-free payments of $5.16 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Sep 1 - Sep 6

Description

Heart health (Major Adverse Cardiovascular Events MACE) early evidence suggests a possible cardiovascular benefit, with a large dedicated outcomes trial underway to confirm this (JAMA Network Open, 2024)

eccogene glp-1 Nonclinical and firstinhuman characterization of ECC5004/AZD5004, a novel oncedaily, oral smallmolecule GLP1 receptor agonist - Haggag - 2025 - Diabetes, Obesity and Metabolism 9 Companies Developing Next-Generation GLP-1

Pharmacologic evaluation of sulfasalazine, FTY720, and anti-IL-12/23p40 in a TNBS-induced Crohns disease model

eccogene glp-1 Nonclinical and firstinhuman characterization of ECC5004/AZD5004, a novel oncedaily, oral smallmolecule GLP1 receptor agonist - Haggag - 2025 - Diabetes, Obesity and Metabolism 9 Companies Developing Next-Generation GLP-1

A 68-year-old retiree in Toronto has lived with rheumatoid arthritis for 15 years

eccogene glp-1 Nonclinical and firstinhuman characterization of ECC5004/AZD5004, a novel oncedaily, oral smallmolecule GLP1 receptor agonist - Haggag - 2025 - Diabetes, Obesity and Metabolism 9 Companies Developing Next-Generation GLP-1

This makes it particularly useful for horses where efficient energy production matters - whether that's maintaining muscle tone, supporting training, helping older horses stay active, or supporting horses managed on lower-calorie diets

eccogene glp-1 Nonclinical and firstinhuman characterization of ECC5004/AZD5004, a novel oncedaily, oral smallmolecule GLP1 receptor agonist - Haggag - 2025 - Diabetes, Obesity and Metabolism 9 Companies Developing Next-Generation GLP-1

It can be sterile water (no preservative, single use) or bacteriostatic water (with preservative, multi-dose), so not all reconstitution water is bacteriostatic.

eccogene glp-1 Nonclinical and firstinhuman characterization of ECC5004/AZD5004, a novel oncedaily, oral smallmolecule GLP1 receptor agonist - Haggag - 2025 - Diabetes, Obesity and Metabolism 9 Companies Developing Next-Generation GLP-1
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products

Japanese
Japanese

US$ 24.50

Min. order: 1 piece

4.9 (25 reviews)

Sold : Login>>